Autismus und Sehen « Le Syndrome de Schorderet- Munier ... - ophta

KONGRESSE /CONGRES
Références
1 Crabb DP, Fitzke FW, Hitchings RA, Viswanathan
AC. A practical approach to measuring the visual
field component of fitness to drive. Br J Ophthalmol
2004;88:1191–1196.
2 Weinreb RN, Friedman DS, Fechtner RD, et al.
Risk assessment in the management of patients
with ocular hypertension. Am J Ophthalmol
2004;138:458–467.
3 Yücel YH, Zhang Q, Weinreb RN, et al. Effects of
retinal ganglion cell loss on magno-, parvo-, koniocellular
pathways in the lateral geniculate nucleus
and visual cortex in glaucoma. Prog Retin Eye Res
2003;22:465–481.
4 Sample PA, Medeiros FA, Racette L, et al. Identifying
glaucomatous vision loss with visual-functionspecific
perimetry in the diagnostic innovations
in glaucoma study. Invest Ophthalmol Vis Sci
2006;47:3381–3389.
5 Stewart WC, Konstas AG, Nelson LA, Kruft B. Metaanalysis
of 24-hour intraocular pressure studies
evaluating the efficacy of glaucoma medicines.
Ophthalmology 2008;115:1117-1122.e1.
6 Konstas AG, Kozobolis VP, Tsironi S, et al. Comparison
of the 24-hour intraocular pressure-lowering
effects of latanoprost and dorzolamide/timolol fixed
combination after 2 and 6 months of treatment.
Ophthalmology 2008;115:99–103.
7 Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival
proinflammatory and preapoptotic effects of
latanoprost and preserved and unpreserved timolol:
an ex vivo and in vitro study. Invest Ophthalmol Vis
Sci 2004;45:1360–1368.
8 Schiller PH, Logothetis NK, Charles ER. Functions
of the colour-opponent and broad-band channels of
the visual system. Nature 1990;343:68–70.
9 Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL.
Nocturnal arterial hypotension and its role in optic
nerve head and ocular ischemic disorders. Am J
Ophthalmol 1994;117:603–624.
10 Pillunat LE, Anderson DR, Knighton RW, et al. Autoregulation
of human optic nerve head circulation in
response to increased intraocular pressure. Exp Eye
Res 1997;64:737–744.
11 Pillunat LE, Lang GK, Harris A. The visual response
to increased ocular blood flow in normal pressure
glaucoma. Surv Ophthalmol 1994;38 Suppl:
S139–147;discussion S147–148.
12 Petropoulos IK, Pournaras JA, Munoz JL, Pournaras
CJ. Effect of carbogen breathing and acetazolamide
on optic disc PO2. Invest Ophthalmol Vis Sci
2005;46:4139–4146.
13 Michalk F, Michelson G, Harazny J, et al. Single-dose
nimodipine normalizes impaired retinal
circulation in normal tension glaucoma. J Glaucoma
2004;13:158–162.
14 Luksch A, Rainer G, Koyuncu D, et al. Effect of
nimodipine on ocular blood flow and colour contrast
sensitivity in patients with normal tension glaucoma.
Br J Ophthalmol 2005;89:21–25.
15 Rolle T, Tofani F, Brogliatti B, Grignolo FM. The
effects of dorzolamide 2% and dorzolamide/timolol
fixed combination on retinal and optic nerve
head blood flow in primary open-angle glaucoma
patients. Eye 2008; doi:10.1038/sj.eye.6703071.
16 Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal
blood pressure reduction on circadian fluctuation
of mean ocular perfusion pressure: a risk factor for
normal tension glaucoma. Invest Ophthalmol Vis Sci
2006;47:831–836.
17 Choi J, Kim KH, Jeong J, et al. Circadian fluctuation
of mean ocular perfusion pressure is a consistent
risk factor for normal-tension glaucoma. Invest
Ophthalmol Vis Sci 2007;48:104–111.
18 Leske MC, Heijl A, Hyman L, et al. Predictors of longterm
progression in the early manifest glaucoma
trial. Ophthalmology 2007;114:1965–1972.
19 Bertschinger DR, Mendrinos E, Dosso A. Yoga can
be dangerous – glaucomatous visual field defect
worsening due to postural yoga. Br J Ophthalmol
2007;91:1413–1414.
20 Teng C, Gurses-Ozden R, Liebmann JM, et al. Effect
of a tight necktie on intraocular pressure. Br J
Ophthalmol 2003;87:946–948.
21 Mozaffarieh M, Flammer J. Is there more to glaucoma
treatment than lowering IOP? Surv Ophthalmol
2007;52 Suppl.2:S174–179.
22 Hare WA, WoldeMussie E, Weinreb RN, et al. Efficacy
and safety of memantine treatment for reduction of
changes associated with experimental glaucoma in
monkey, II: Structural measures. Invest Ophthalmol
Vis Sci 2004;45:2640–2651.
23 Yücel YH, Gupta N, Zhang Q, et al. Memantine
protects neurons from shrinkage in the lateral
geniculate nucleus in experimental glaucoma. Arch
Ophthalmol 2006;124:217–225.
24 Damji KF, Bovell AM, Hodge WG, et al. Selective laser
trabeculoplasty versus argon laser trabeculoplasty:
results from a 1-year randomised clinical trial. Br J
Ophthalmol 2006;90:1490–1494.
25 Tsai JC, McClure CA, Ramos SE, et al. Compliance
barriers in glaucoma: a systematic classification. J
Glaucoma 2003;12:393–398.
26 Birt CM. Selective laser trabeculoplasty retreatment
after prior argon laser trabeculoplasty: 1-year
results. Can J Ophthalmol 2007;42:715–719.
27 AGIS Investigators. The Advanced Glaucoma Intervention
Study (AGIS): 9. Comparison of glaucoma
outcomes in black and white patients within treatment
groups. Am J Ophthalmol 2001;132:311–320.
28 Jakobi PC, Krieglstein GK. Trabecular aspiration: a
new surgical approach to improve trabecular facility
in pseudoexfoliation glaucoma. Int Ophthalmol
1994;18:153–157.
29 Jakobi PC, Dietlein TS, Krieglstein GK. Comparative
study of trabecular aspiration vs trabeculectomy
in glaucoma triple procedure to treat pseudoexfoliation
glaucoma. Arch Ophthalmol 1999;
117:1311–1318.
30 Thomas R, George R, Parikh R, et al. Five year risk
of progression of primary angle closure suspects to
primary angle closure: a population based study. Br
J Ophthalmol 2003;87:450–454.
31 Sihota R, Lakshmaiah NC, Walia KB, et al. The
trabecular meshwork in acute and chronic
angle closure glaucoma. Indian J Ophthalmol
2001;49:255–259.
32 Nolan WP, See JL, Chew PT, et al. Detection of primary
angle closure using anterior segment optical
coherence tomography in Asian eyes. Ophthalmology
2007;114:33–39.
33 Sakata LM, Lavanya R, Friedman DS, et al. Assessment
of the scleral spur in anterior segment optical
coherence tomography images. Arch Opththalmol
2008;126:181–185.
Correspondance :
Dr Ioannis K. Petropoulos
Centre Ophtalmologique
de la Terrassière
Rue de la Terrassière 31
1207 Genève
Tél. 022 7 35 48 33
Fax 022 735 49 57
ipetropoulos@cot-ge.ch
* Le symposium était organisé par
l’hôpital ophtalmique Moorfields et
sponsorisé par MSD Ophthalmics.
288 ophta • 4|2008